Solvotrin Therapeutics Products

Solvotrin’s lead product, ST1406 (also known as ACTIVE IRON™) is clinically proven to outperform market leading oral iron supplements in an iron deficiency market worth more than $10.0 Billion.

ACTIVE IRON and Iron Deficiency

Iron deficiency is the most common form of malnutrition, affecting 2 billion people worldwide. It is the only nutrition deficiency common in both developed and developing countries. It is the most common cause of anaemia and is prevalent in women of childbearing age, children and older people.

ACTIVE IRON Performance

The current world market is dominated by a range of poorly absorbed and poorly tolerated products. ACTIVE IRON™ is a ferrous sulfate supplement with a unique, protected formulation. ACTIVE IRON™ was developed to boost iron absorption while improving the gastrointestinal tolerability and taste characteristics of oral iron.”

For more information please see the ACTIVE IRON website.